Editors: Atta-ur-Rahman, FRS, M. Iqbal Choudhary

Anti-Angiogenesis Drug Discovery and Development

Volume 1

eBook: US $34 Special Offer (PDF + Printed Copy): US $136
Printed Copy: US $119
Library License: US $136
ISSN: 2452-3240 (Print)
ISSN: 2210-268X (Online)
ISBN: 978-1-60805-648-4 (Print)
ISBN: 978-1-60805-162-5 (Online)
Year of Publication: 2011
DOI: 10.2174/97816080516251110101

Introduction

The inhibition of angiogenesis is an effective mechanism of slowing down tumor growth and malignancies. The process of induction or pro-angiogenesis is highly desirable for the treatment of cardiovascular diseases, wound healing disorders, etc. Efforts to understand the molecular basis, both for inhibition and induction, have yielded fascinating results.

Anti-angiogenesis Drug Discovery and Development provides an excellent compilation of well-written reviews on various aspects of the anti-angiogenesis process. These reviews have been contributed by leading practitioners in drug discovery science and highlight the major developments in this exciting field in the last two decades. The feast of these reader-friendly reviews on topics of great scientific importance – many of which are considered significant medical breakthroughs, makes this book excellent reading both for the novice as well as for expert medicinal chemists and clinicians.

Indexed in: Scopus, EBSCO, Ulrich's Periodicals Directory.

Preface

- Pp. i-iii (3)
Atta-ur-Rahman, M. Iqbal Choudhary
Download Free

Contributors

- Pp. iv-vi (3)
Atta-ur-Rahman, M. Iqbal Choudhary
View Abstract

Antiangiogenic Treatment of Hematological Tumors

- Pp. 1-11 (11)
Domenico Ribatti, Vito Longo, Angelo Vacca
View Abstract

Multiligands/Rage Axis: An Emerging Actor in Tumour Angiogenesis

- Pp. 12-33 (22)
Armando Rojas, Hector Figueroa, Ileana Gonzalez, Jacqueline Romero, Miguel Morales
View Abstract

Ginsenoside Rg3 and Rh2: The Anti-Cancer and Anti- Angiogenic Saponins from Ginseng

- Pp. 34-57 (24)
Patrick Y.K. Yue, Y. Huang, Ricky N.S. Wong
View Abstract

Antiangiogenic Therapy for Cardiovascular Diseases

- Pp. 58-69 (12)
Mustafa Sacar, Yalın Tolga Yaylali
View Abstract

Role of Phosphoinositide 3-Kinases and Angiogenesis in Cardiovascular Diseases

- Pp. 70-85 (16)
Cinzia Perrino, Giovanni Esposito, Giuseppe Gargiulo, Gianluigi Pironti, Gabriele G. Schiattarella, Massimo Chiariello
View Abstract

Redox Regulation of Angiogenesis: NADPH Oxidase as a Drug Target

- Pp. 86-115 (30)
Elsa C. Chan, Hitesh Peshavariya, Srinivasa Raju Datla, Gregory J. Dusting, Fan Jiang
View Abstract

Thymidine Phosphorylase Inhibitors

- Pp. 116-147 (32)
Radim Nencka
View Abstract

Neurological Complications of Antiangiogenic Therapy

- Pp. 148-170 (23)
Jose Tarcisio Feitosa Vieira da Silva, Italo Gustavo Lima Monteiro, Carlos Tairo Diogenes Holanda, Francisco de Assis Aquino Gondim
View Abstract

Autoimmunity and Angiogenesis

- Pp. 171-186 (16)
A. Mirshafiey, R. Boghozian
View Abstract

Author Index to Volume 1

- Pp. 187
Atta-ur-Rahman, M. Iqbal Choudhary
View Abstract

RELATED BOOKS

.Biotechnology and Drug Development for Targeting Human Diseases.
.Enzymatic Targets for Drug Discovery Against Alzheimer
.Applied Computer-Aided Drug  Design: Models and Methods.
.Medicinal Plants, Phytomedicines and Traditional Herbal Remedies for Drug Discovery and Development against COVID-19.